L310-0156 Screening compound: 6-chloro-N-(3-fluoro-4-methylphenyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

L310-0156 Screening compound: 6-chloro-N-(3-fluoro-4-methylphenyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide
L310-0156 Screening compound: 6-chloro-N-(3-fluoro-4-methylphenyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L310-0156
6-chloro-N-(3-fluoro-4-methylphenyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L310-0156

Molecular Formula

C19H16ClFN4O5S (C19 H16 ClFN4 O5 S)

Compound Name

6-chloro-N-(3-fluoro-4-methylphenyl)-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-7-sulfonamide

IUPAC name

6-chloro-N-(3-fluoro-4-methylphenyl)-4-[(5-methyl-124-oxadiazol-3-yl)methyl]-3-oxo-34-dihydro-2H-14-benzoxazine-7-sulfonamide

SMILES

Cc1nc(CN(C(COc2c3)=O)c2cc(Cl)c3S(Nc2cc(F)c(C)cc2)(=O)=O)no1

InChI

InChI=1S/C19H16ClFN4O5S/c1-10-3-4-12(5-14(10)21)24-31(27,28)17-7-16-15(6-13(17)20)25(19(26)9-29-16)8-18-22-11(2)30-23-18/h3-7,24H,8-9H2,1-2H3

InChI Key

UILYXDAHCZCLFT-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244280

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

466.88

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.046

Distribution Coefficient, logD

2.979

Water Solubility, LogSw

-3.46

Polar Surface Area

96.885

Acid Dissociation Constant (pKa)

8.18

Base Dissociation Constant (pKb)

-4.69

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.10

L310-0156 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Neuropeptide S Library (2850 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Nervous system
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L310-0156 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L310-0156?
Check Price and Availability of L310-0156, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L310-0156 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L310-0156
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L310-0156
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L310-0156 available by request